Arteris, Inc.·4

Jul 7, 4:22 PM ET

Kunkel Joachim 4

4 · Arteris, Inc. · Filed Jul 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Arteris Director Joachim Kunkel Receives 365-Share Award

What Happened

  • Joachim Kunkel, a director of Arteris, Inc. (AIP), was granted 365 shares of restricted common stock on July 5, 2026. The shares were issued at $0 (award/grant) and are fully vested.
  • The grant value was calculated using the company’s average trading price of $39.28 (May 20–July 2, 2026), valuing the award at approximately $14,337.20. These shares represent retainer fees Kunkel elected to receive in stock instead of cash.

Key Details

  • Transaction date: July 5, 2026; Form 4 filed July 7, 2026 (timely filing).
  • Transaction type/code: Award/Grant (A). Price to insider: $0.00 per share.
  • Shares granted: 365; estimated value based on $39.28 average = $14,337.20.
  • Shares owned after transaction: not disclosed in this filing.
  • Footnotes: F1 — shares are fully vested restricted stock representing retainer fees elected in lieu of cash; F2 — the reporting person elected to defer receipt of shares.
  • Interpretation: This was a compensation award (not a market purchase or sale) and reflects payment of director retainer fees, not an open-market investment.

Context

  • Awards of vested restricted stock are compensation and do not necessarily indicate the insider’s view on the stock’s near-term prospects. Because these shares were fully vested and represent deferred retainer fees, they are routine director compensation rather than a trading signal.

Insider Transaction Report

Form 4
Period: 2026-07-05
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-07-05+36574,695 total
Footnotes (2)
  • [F1]Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on July 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from May 20, 2026 through July 2, 2026, which was $39.28.
  • [F2]The Reporting Person elected to defer the receipt of shares.
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim|2026-07-07

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT